Response by Maurer and Fontana to Letter Regarding Article, "Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial".

IF 41.3 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

Circulation Pub Date : 2026-09-22 Epub Date: 2026-09-21 DOI:10.1161/CIRCULATIONAHA.126.080972

Mathew S Maurer, Marianna Fontana

引用次数: 0

查看原文本刊更多论文

Maurer和Fontana对文章“Coramitug，一种人源化单克隆抗体治疗转甲状腺素淀粉样心肌病：随机、多中心、双盲、安慰剂对照试验”的回应。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Circulation 医学-外周血管病

CiteScore

45.70

自引率

2.10%

发文量

1473

审稿时长

2 months

期刊介绍： Circulation is a platform that publishes a diverse range of content related to cardiovascular health and disease. This includes original research manuscripts, review articles, and other contributions spanning observational studies, clinical trials, epidemiology, health services, outcomes studies, and advancements in basic and translational research. The journal serves as a vital resource for professionals and researchers in the field of cardiovascular health, providing a comprehensive platform for disseminating knowledge and fostering advancements in the understanding and management of cardiovascular issues.